| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $6.4B | $6.4B | $5.9B | $3.6B | $1.3B | $1.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-0.7B | $0.1B | $-0.7B | $1.0B | $1.1B | $-0.4B | $0.0B | $0.1B |
| Net Income | $-0.8B | $-0.3B | $-0.5B | $0.2B | $0.4B | $-0.7B | $0.0B | $0.1B |
| EPS (Basic) | $-5.83 | $-2.05 | $-3.22 | $1.37 | $2.64 | $-5.00 | $-0.80 | $-0.37 |
| EPS (Diluted) | $-5.83 | $-2.05 | $-3.22 | $1.29 | $2.48 | $-5.00 | $-0.80 | $-0.37 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.3B | $15.3B | $16.1B | $17.5B | $16.9B | $14.7B | $14.2B | $11.0B |
| Current Assets | $1.2B | $1.2B | $1.7B | $2.0B | $2.2B | $2.1B | $0.6B | $0.7B |
| Cash & Equivalents | $0.7B | $0.7B | $1.1B | $1.6B | $1.9B | $1.9B | $0.4B | $0.5B |
| Total Liabilities | $12.4B | $12.4B | $12.9B | $13.9B | $12.8B | $12.0B | $12.3B | $10.2B |
| Current Liabilities | $1.5B | $1.4B | $1.5B | $1.2B | $1.1B | $0.9B | $0.9B | $0.7B |
| Stockholders' Equity | $1.8B | $2.9B | $3.2B | $3.6B | $4.1B | $2.7B | $1.9B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.4B | $0.5B | $0.9B | $0.9B | $0.3B | $0.7B | $0.4B |
| Investing Cash Flow | $-0.4B | $-0.5B | $-0.7B | $-0.3B | $-1.2B | $-0.2B | $-0.6B | $-1.4B |
| Capital Expenditures | — | — | — | $0.3B | $0.2B | $0.1B | $0.2B | $0.1B |
| Financing Cash Flow | $-0.2B | $-0.2B | $-0.3B | $-0.9B | $0.3B | $1.3B | $-0.1B | $1.3B |